Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

Clinical trial NCT00546078 · COMPLETED

Trial details

NCT number: NCT00546078
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Infections, Papillomavirus

Start date: 2008-01-14
Primary completion: 2008-12-22
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.